Evidence for Population Health

Evidence for Population Health

Volumn , Issue , 2009, Pages 1-144

  Heller, Richard ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Clinical practice; Evidence for population health; Population impact measures; Public health; Public health policy making

Indexed keywords

EID: 33750054924     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780198529743.001.0001     Document Type: Book

References (162)

1. Rychetnik L., Frommer M., Hawe P., Shiell A. Criteria for evaluating evidence on public health interventions. J. Epidemiol. Community Health 2002; 56: 119-27.
2. Bhopal R. Concepts of Epidemiology: an integrated introduction to the ideas, theories, principles and methods of epidemiology. Oxford: Oxford University Press, 2002.
3. Dobrow M. J., Goel V., Upshur R. E. Evidence-based health policy: context and utilisation. Soc. Sci. Med. 2004; 58: 207-17.
4. Singer P. A., Martin D. K., Giacomini M., Purdy L. Priority setting for new technologies in medicine: qualitative case study. BMJ 2000; 321: 1316-18.
5. Elliott H., Popay J. How are policy makers using evidence? Models of research utilisation and local NHS policy making. J. Epidemiol. Community Health 2000; 54: 461-8.
6. Rosenstock L. and Lee L. J. Attacks on science: the risks to evidence-based policy. Am. J. Public Health 2002; 92: 14-18.
7. Lomas J., Fulop N., Gagnon D., Allen P. On being a good listener: setting priorities for applied health services research. Milbank Q. 2003; 81: 363-88.
8. Coffield A. B., Maciosek M. V., McGinnis J. M., Harris J. R., Caldwell M. B., Teutsch S. M. et al. Priorities among recommended clinical preventive services. Am. J. Prev. Med. 2001; 21: 1-9.
9. Macintyre S., Chalmers I., Horton R., Smith R. Using evidence to inform health policy: case study. BMJ 2001; 322: 222-5.
10. Davey S. G., Ebrahim S., Frankel S. How policy informs the evidence. BMJ 2001; 322: 184-5.
11. Black N. Evidence-based policy: proceed with care. BMJ 2001; 323: 275-9.
12. Donald A. Commentary: research must be taken seriously. BMJ 2001; 323: 278-9.
13. Walshe K. Evidence-based policy: don't be timid. BMJ 2001; 323: 1187.
14. Walshe K. and Rundall T. G. Evidence-based management: from theory to practice in health care. Milbank Q. 2001; 79: 429-57.
15. Singer P. A. Resource allocation: beyond evidence-based medicine and costeffectiveness analysis. ACP J. Club. 1997; 127: A16-18.
16. The periodic health examination. Canadian Task Force on the Periodic Health Examination. Can. Med. Assoc. J. 1979; 121: 1193-254.
17. Lawrence R. S., Mickalide A. D., Kamerow D. B., Woolf S. H. Report of the US Preventive Services Task Force. JAMA 1990; 263: 436-7.
18. Petticrew M. and Roberts H. Evidence, hierarchies, and typologies: horses for courses. J. Epidemiol. Community Health 2003; 57: 527-9.
19. Habicht J. P., Victora C. G., Vaughan J. P. Evaluation designs for adequacy, plausibility and probability of public health programme performance and impact. Int. J. Epidemiol. 1999; 28: 10-8.
20. Rychetnik L., Frommer M., Hawe P., Shiell A. Criteria for evaluating evidence on public health interventions. J. Epidemiol. Community Health 2002; 56: 119-27.
21. Kirkwood B. R., Cousens S. N., Victora C. G., de Z, I. Issues in the design and interpretation of studies to evaluate the impact of community-based interventions. Trop. Med. Int. Health 1997; 2: 1022-9.
22. Des J., Lyles C., Crepaz N. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am. J. Public Health 2004; 94: 361-6.
23. Rosenstock L. and Lee L. J. Attacks on science: the risks to evidence-based policy. Am. J. Public Health 2002; 92: 14-8.
24. Thompson B., Lichtenstein E., Corbett K., Nettekoven L., Feng Z. Durability of tobacco control efforts in the 22 Community Intervention Trial for Smoking Cessation (COMMIT) communities two years after the end of intervention. Health Educ. Res. 2000; 15: 353-66.
25. Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996; 312: 1215-18.
26. Stampfer M. Observational epidemiology is the preferred means of evaluating effects of behavioral and lifestyle modification. Control Clin. Trials 1997; 18: 494-9.
27. Britton A., McKee M., Black N., McPherson K., Sanderson C., Bain C. Choosing between randomised and non-randomised studies:a systematic review. Health Technol. Assess. 1998; 2: 1-124.
28. Concato J., Shah N., Horwitz R. I. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N. Engl. J. Med. 2000; 342: 1887-92.
29. Benson K. and Hartz A. J. A comparison of observational studies and randomized, controlled trials. N. Engl. J. Med. 2000; 342: 1878-86.
30. Michels K. B. and Manson J. E. Postmenopausal hormone therapy: a reversal of fortune. Circulation 2003; 107: 1830-3.
31. Concato J. and Horwitz R. I. Beyond randomised versus observational studies. Lancet 2004; 363: 1660-1.
32. Lawlor D. A., Davey S. G., Kundu D., Bruckdorfer K. R., Ebrahim S. Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? Lancet 2004; 363: 1724-7.
33. Vandenbroucke J. P. When are observational studies as credible as randomised trials? Lancet 2004; 363: 1728-31.
34. Victora C. G., Habicht J. P., Bryce J. Evidence-based public health: moving beyond randomized trials.. Am. J. Public Health 2004; 94: 400-5.
35. O'Connor A. M., Legare F., Stacey D. Risk communication in practice: the contribution of decision aids. BMJ 2003; 327: 736-40.
36. Heller R. F., Heller T. D., Pattison S. Putting the public back into public health. Part II. How can public health be accountable to the public? Public Health 2003; 117: 66-71.
37. McElduff P., Lyratzopoulos G., Edwards R., Heller R. F., Shekelle P., Roland M. Will changes in primary care improve health outcomes? Modelling the impact of financial incentives introduced to improve quality of care in the UK. Qual Saf Health Care 2004; 13: 191-7.
38. Brindle P., Emberson J., Lampe F., Walker M., Whincup P., Fahey T., et al. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 2003; 327: 1267.
39. McElduff P., Lyratzopoulos G., Edwards R., Heller R. F., Shekelle P., Roland M. Will changes in primary care improve health outcomes? Modelling the impact of financial incentives introduced to improve quality of care in the UK. Qual. Saf Health Care 2004; 13: 191-7.
40. Kelly H., Attia J., Andrews R., Heller R. F. The number needed to vaccinate (NNV) and population extensions of the NNV: comparison of influenza and pneumococcal vaccine programmes for people aged 65 years and over. Vaccine 2004; 22: 2192-8.
41. Aaby P., Bhuiya A., Nahar L., Knudsen K., de Francisco A., Strong M. The survival benefit of measles immunization may not be explained entirely by the prevention of measles disease:a community study from rural Bangladesh. Int. J. Epidemiol. 2003; 32: 106-16.
42. Kabir Z., Long J., Reddaiah V. P., Kevany J., Kapoor S. K. Non-specific effect of measles vaccination on overall child mortality in an area of rural India with high vaccination coverage: a population-based case-control study. Bull. World Health Organ 2003; 81: 244-50.
43. Zaidi A. K., Awasthi S., deSilva H. J. Burden of infectious diseases in South Asia. BMJ 2004; 328: 811-15.
44. Heller R. F., Buchan I., Edwards R., Lyratzopoulos G., McElduff P., St Leger S. Communicating risks at the population level: application of population impact numbers. BMJ 2003; 327: 1162-5.
45. Walker A., O'Brien M., Traynor J., Fox K., Goddard E., Foster, K. Living in Britain 2001:Health Survey for England 2001. London, The Stationery Office: Office for National Statistics, 2002.
46. Tan L. B. and Murphy R. Shifts in mortality curves: saving or extending lives? Lancet 1999; 354: 1378-81.
47. Stahl E., Jansson S. A., Jonsson A. C., Svensson K., Lundback B., Andersson F. Health-related quality of life, utility, and productivity outcomes instruments: ease of completion by subjects with COPD. Health Qual. Life Outcomes 2003; 1: 18.
48. Nutbeam D. Health literacy as a public health goal: a challenge for contemporary health education and communication strategies into the 21st century. Health Promot. Int. 2000; 15: 259-67.
49. Renkert S. and Nutbeam D. Opportunities to improve maternal health literacy through antenatal education: an exploratory study. Health Promot. Int. 2001; 16: 381-8.
50. Williams A. QALYS and ethics: a health economist's perspective. Soc. Sci. Med. 1996; 43: 1795-804.
51. Oliver A. Putting the quality into quality-adjusted life years. J. Public Health Med. 2003; 25: 8-12.
52. Oliver A., Healey A., Le Grand J. Addressing health inequalities.. Lancet 2002; 360: 565-7.
53. Oliver A. On health inequality. J. Public Health Med. 2000; 22: 454-6.
54. NSW Chief Health Officer. Report of the NSW ChiefHealth Officer. New South Wales, Australia, NSW Health, 2002.
55. Tobias M. and Jackson G. Avoidable mortality in New Zealand, 1981-97. Aust. N. Z. J. Public Health 2001; 25: 12-20.
56. Tobias M. I. and Cheung J. Monitoring health inequalities: life expectancy and small area deprivation in New Zealand. Popul. Health Metr. 2003; 1: 2.
57. Nolte E. and McKee M. Measuring the health of nations: analysis of mortality amenable to health care. BMJ 2003; 327: 1129.
58. Regidor E., Calle M. E., Dominguez V., Navarro P. Inequalities in mortality in shrinking and growing areas. J. Epidemiol. Community Health 2002; 56: 919-21.
59. Heller R. F., McElduff P., Edwards R. Impact of upward social mobility on population mortality: analysis with routine data. BMJ 2002; 325: 134-6.
60. Naylor C. D. and Guyatt G. H. Users' guides to the medical literature. X. How to use an article reporting variations in the outcomes of health services. The Evidence-Based Medicine Working Group. JAMA 1996; 275: 554-8.
61. Heller T. D., Heller R. F., Pattison S., Fletcher R. Treating the patient or the population? Part 1. Judging the benefit of treatment of individual patients. West J. Med. 2001; 175: 35-7.
62. Heller T. D., Heller R. F., Pattison S., Fletcher R. Treating the patient or the population? Part 2. Judging the benefit of a treatment to society as a whole. West J. Med. 2001; 175: 104-7.
63. Dolan P., Cookson R., Ferguson B. Effect of discussion and deliberation on the public's views of priority setting in health care: focus group study. BMJ 1999; 318: 916-19.
64. Heller R. F., Heller T. D., Pattison S. Putting the public back into public health. Part I. A re-definition of public health. Public Health 2003; 117: 62-5.
65. Heller R. F., Heller T. D., Pattison S. Putting the public back into public health. Part II. How can public health be accountable to the public? Public Health 2003; 117: 66-71.
66. Murray S. A. Experiences with 'rapid appraisal' in primary care: involving the public in assessing health needs, orientating staff, and educating medical students.. BMJ 1999; 318: 440-4.
67. Sandars J. Knowledge management: something old, something new! Work Based Learning in Primary Care 2004; 2: 9-17.
68. Forsetlund L. and Bjorndal A. The potential for research-based information in public health: identifying unrecognised information needs. BMC. Public Health 2001; 1: 1.
69. Saunders P., Mathers J., Parry J., Stevens A. Identifying 'non-medical' datasets to monitor community health and well-being. J. Public Health Med. 2001; 23: 103-8.
70. Black N. and Payne M. Improving the use of clinical databases. BMJ 2002; 324:1194.
71. Heller R. F. and Page J. H. A population perspective to evidence-based medicine:'evidence for population health'. Journal of Epidemiology and Community Health 2002; 56: 45-7.
72. Kwiatkowski R. E. and Ooi M. Integrated environmental impact assessment: a Canadian example. Bull. World Health Organ 2003; 81: 434-8.
73. Serquina-Ramiro L., Kasniyah N., Inthusoma T., Higginbotham N., Streiner D., Nichter M., et al. Measles immunization acceptance in Southeast Asia: past patterns and future challenges. Southeast Asian J. Trop. Med. Public Health 2001; 32: 791-804.
74. Grimshaw J. M., Shirran L., Thomas R., Mowatt G., Fraser C., Bero L., et al. Changing provider behavior: an overview of systematic reviews of interventions. Med. Care 2001; 39: 112-45.
75. Rothman K. J. and Greenland S. Modern Epidemiology. Philadelphia: Lippincott-Raven, 1998.
76. Levin M. L. The occurrence of lung cancer in man. Acta Unio Inter Contra Cancrum 1953; 19: 531.
77. Heller R. F., Dobson A. J., Attia J., Page J. H. Impact numbers: measures of risk factor impact on the whole population from case control and cohort studies. Journal of Epidemiology and Community Health 2002; 56: 606-10.
78. Doll R. and Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. BMJ 1976; 2: 1525-36.
79. Heller R. F. and Dobson A. J. Disease impact number and population impact number: a population perspective to measures of risk and benefit. BMJ 2000; 321: 950-2.
80. Heller R. F., Buchan I., Edwards R., Lyratzopoulos G., McElduff P., St Leger S. Communicating risks at the population level: application of population impact numbers. BMJ 2003; 327: 1162-5.
81. McPherson K., Britton A., Causer L. Coronary Heart Disease. Estimating the impact of changes in risk factors. London: The Stationery Office: National Heart Forum, 2002.
82. Morgenstern H. and Bursic E. A method for using epidemiologic data to estimate the potential impact of an intervention on the health status of a target population. Journal of Community Health 1982; 7: 292-309.
83. Browner W. S. Estimating the impact of risk factor modification programs. Am. J. Epidemiol. 1986; 123: 143-53.
84. Laupacis A., Sackett D. L., Roberts R. S. An assessment of clinically useful measures of the consequences of treatment. N. Engl. J. of Med. 1988; 318: 1728-33.
85. Heller R. F., Powell H., O'Connell R. L., D'Este K., Lim L. L. Trends in the hospital management of unstable angina. Journal of Epidemiology and Community Health 2001; 55: 483-6.
86. Kristiansen I. S. and Gyrd-Hansen D. Cost-effectiveness analysis based on the number-needed-to-treat: common sense or non-sense? Health Econ. 2004; 13: 9-19.
87. Heller R. F., Sandars J., Patterson L., McElduff P. GPs' and physicians' interpretation of risks, benefits and diagnosis test results. Fam. Pract. 2004; 21: 155-9.
88. Kristiansen I. S., Gyrd-Hansen D., Nexoe J., Nielsen J. B. Number needed to treat: easily understood and intutitively meaningful? Theoretical considerations and a randomised trial. Journal of Clinical Epidemiology 2002; 55: 888-92.
89. Wu L. A. and Kottke T. E. Number needed to treat: caveat emptor. J. Clin. Epidemiol. 2001; 54: 111-16.
90. Heller R. F., Edwards R., McElduff P. Implementing guidelines in primary care:can population impact measures help? BMC Public Health 2003; 3: 7.
91. Hersh A. L., Black W. C., Tosteson A. N. Estimating the population impact of an intervention: a decision-analytic approach. Stat. Methods Med. Res. 1999; 8: 311-30.
92. Heller R. F., Langhorne P., James E. Improving stroke outcome: the benefits of increasing availability of technology.. Bulletin of the World Health Organization 2000; 78: 1337-43.
93. European Centre for Health Policy. Gothenburg Consensus Paper. 1999. WHO Regional Office for Europe.
94. Kemm J., Parry J., Palmer S. Health Impact Assessment-Concepts, theory, techniques and applications. Oxford: Oxford University Press, 2004.
95. Kwiatkowski R. E. and Ooi M. Integrated environmental impact assessment: a Canadian example. Bull. World Health Organ 2003; 81: 434-8.
96. Kjellstrom T., van Kerkhoff L., Bammer G., McMichael T. Comparative assessment of transport risks-how it can contribute to health impact assessment of transport policies. Bull. World Health Organ 2003; 81: 451-7.
97. Murray C. J. L. and Lopez A. D. The Global Burden of Disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard School of Public Health on behalf of the World Health Organization and The World Bank, 1966.
98. Mathers C. D., Stein C., Ma Fat D., Rao C., Inoue M., Tomijima N., Berbard C., Lopez A. D., and Murray C. J. L. Global Burden of Disease 2000:version 2 methods and results. Geneva: World Health Organization, Global Programme on Evidence for Health Policy Discussion Paper No. 50, 2002. Internet communication at web site .
99. Manuel D. and Schultz S. Using linked data to calculate summary measures of population health: Health-adjusted life expectancy of people with Diabetes Mellitus. Population Health Metrics 2004; 2: 4.
100. World Health Organization. The World Health Report 2002: reducing risks, promoting healthy life. Geneva: World Health Organization, 2002.
101. Ezzati M., Hoorn S. V., Rodgers A., Lopez A. D., Mathers C. D., Murray C. J. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 2003; 362: 271-80.
102. Attia J., Page J., Heller, R. F., Dobson A. J. Impact numbers in health policy decisions. Journal of Epidemiology and Community Health 2002; 56: 600-5.
103. Horton R. The lessons of MMR. Lancet 2004; 363: 747-9.
104. Heller R. F. and Heller T. A failure of public trust. Practitioner 2002; 246: 511.
105. Heller T. Ethical debate: Vaccination against mumps, measles, and rubella: is there a case for deepening the debate? How safe is MMR vaccine? BMJ 2001; 323: 838-9.
106. Heller D., Heller T., Patison S. MMR vaccine debate: authors' summary of responses. BMJ 2002; 324: 733.
107. Edwards A., Unigwe S., Elwyn G., Hood K. Effects of communicating individual risks in screening programmes: Cochrane systematic review. BMJ 2003; 327: 703-9.
108. Calman K. C. Communication of risk: choice, consent, and trust.. Lancet 2002; 360: 166-8.
109. Edwards A., Elwyn G., Mulley A. Explaining risks: turning numerical data into meaningful pictures. BMJ 2002; 324: 827-30.
110. Holmes-Rovner M., Llewellyn-Thomas H., Entwistle V., Coulter A., O'Connor A., Rovner D. R. Patient choice modules for summaries of clinical effectiveness: a proposal. BMJ 2001; 322: 664-7.
111. Department of Health. Communicating about risks to Public Health: Pointers to Good Practice. London: UK Department of Health, 1998.
112. Skolbekken J. A. Communicating the risk reduction achieved by cholesterol reducing drugs. BMJ 1998; 316: 1956-8.
113. McGettigan P., Sly K., O'Connell D., Hill S., Henry D. The effects of information framing on the practices of physicians.. Journal of General Internal Medicine 1999; 14: 633-42.
114. Angell M. and Kassirer J. P. Clinical research-what should the public believe? N. Engl. J. Med. 1994; 331: 189-90.
115. Fahey T., Griffiths S., Peters T. J. Evidence-based purchasing: understanding results of clinical trials and systematic reviews. BMJ 1995; 311: 1056-9.
116. Beck U. Risk Society:towards a new modernity. Translated by Mark Ritter. London:Sage, 1992.
117. Douglas M. Risk and Blame: essays in cultural theory. London: Routledge, 1992.
118. Moynihan R., Bero L., Ross-Degnan D., Henry D., Lee K., Watkins J., et al. Coverage by the news media of the benefits and risks of medications. N. Engl. J. Med. 2000; 342: 1645-50.
119. Social Issues Research Centre. Guidelines on Science and Health Communication. Oxford: Social Issues Research Centre, 2001.
120. Harrabin R., Coote A., Allen J. Health in the News: Risk, reporting and media influence. London: Kings Fund Publications, 2003.
121. Black N. and Payne M. Improving the use of clinical databases. BMJ 2002; 324: 1194.
122. Lundin J., Lundin M., Isola J., Joensuu H. A web-based system for individualised survival estimation in breast cancer. BMJ 2003; 326: 29.
123. Bundred P., Kitchiner D., Buchan I. Prevalence of overweight and obese children between 1989 and 1998: population-based series of cross-sectional studies. BMJ 2001; 322: 326-8.
124. McElduff P., Lyratzopoulos G., Edwards R., Heller R. F., Shekelle P., Roland M. Will changes in primary care improve health outcomes? Modelling the impact of financial incentives introduced to improve quality of care in the UK. Qual. Saf Health Care 2004; 13: 191-7.
125. Virnig B. A. and McBean M. Administrative data for public health surveillance and planning. Annu. Rev. Public Health 2001; 22: 213-30.
126. Powell H., Lim L. L., Heller R. F. Accuracy of administrative data to assess comorbidity in patients with heart disease. an Australian perspective. J. Clin. Epidemiol. 2001; 54: 687-93.
127. Rose G. Sick individuals and sick populations. Int. J. Epidemiol. 2001; 30: 427-32.
128. Body mass index and cardiovascular disease risk factors in seven Asian and five Latin American centers: data from the International Clinical Epidemiology Network (INCLEN). Obes. Res. 1996; 4: 221-8.
129. Rose G. and Day S. The population mean predicts the number of deviant individuals. BMJ 1990; 301: 1031-4.
130. MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J. et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-74.
131. McPherson K., Britton A., Causer L. Coronary Heart Disease. Estimating the impact of changes in risk factors. London: The Stationery Office: National Heart Forum, 2002.
132. Heller R. F., McElduff P., Edwards R. Impact of upward social mobility on population mortality: analysis with routine data. BMJ 2002; 325: 134.
133. Rawls J. A Theory of Justice. Oxford: Clarendon Press, 1972.
134. Lynch J., Smith G. D., Harper S., Hillemeier M., Ross N., Kaplan G. A. et al. Is income inequality a determinant of population health? Part 1. A systematic review. Milbank Q. 2004; 82: 5-99.
135. Susser M. and Susser E. Choosing a future for epidemiology: I. Eras and paradigms. Am. J. Public Health 1996; 86: 668-73.
136. Susser M. and Susser E. Choosing a future for epidemiology: II. From black box to Chinese boxes and eco-epidemiology. Am. J. Public Health 1996; 86: 674-7.
137. Pearce N. Traditional epidemiology, modern epidemiology, and public health. Am. J. Public Health 1996; 86: 678-83.
138. McMichael A. J. Prisoners of the proximate: loosening the constraints on epidemiology in an age of change. Am. J. Epidemiol. 1999; 149: 887-97.
139. Pearce N. The ecological fallacy strikes back. J. Epidemiol. Community Health 2000; 54: 326-7.
140. Yen I. H. and Kaplan G. A. Neighborhood social environment and risk of death:multilevel evidence from the Alameda County Study. Am. J. Epidemiol. 1999; 149: 898-907.
141. Pickett K. E. and Pearl M. Multilevel analyses of neighbourhood socioeconomic context and health outcomes: a critical review.. J. Epidemiol. Community Health 2001; 55: 111-22.
142. Diez-Roux A. V. Bringing context back into epidemiology: variables and fallacies in multilevel analysis. Am. J. Public Health 1998; 88: 216-22.
143. Pearce N. Epidemiology as a population science. Int. J. Epidemiol. 1999; 28: S1015-18.
144. Rose G. Sick individuals and sick populations. Int. J. Epidemiol. 1985; 14: 32-8.
145. Rose G. Sick individuals and sick populations. Int. J. Epidemiol. 2001; 30: 427-32.
146. Ebrahim S. Commentary: Sick populations and sick individuals. Int. J. Epidemiol. 2001; 30: 433-4.
147. Hersh A. L., Black W. C., Tosteson A. N. Estimating the population impact of an intervention: a decision-analytic approach. Stat. Methods Med. Res. 1999; 8: 311-30.
148. Sundquist J., Malmstrom M., Johansson S. E. Cardiovascular risk factors and the neighbourhood environment: a multilevel analysis. Int. J. Epidemiol. 1999; 28: 841-5.
149. Heller R. F. and Page J. H. A population perspective to evidence based medicine:'evidence for population health'. Journal of Epidemiology and Community Health 2002; 56: 45-7.
150. Kindig D. and Stoddart G. What is population health?. Am. J. Public Health 2003; 93: 380-3.
151. Muir Gray J. A. Evidence-Based Health Care. Edinburgh: Churchill Livingstone, 2001.
152. Glasziou P. and Longbottom H. Evidence-based public health practice. Aust. N. Z. J. Public Health 1999; 23: 436-40.
153. Gray J. A. Evidence-based public health-what level of competence is required? J. Public Health Med. 1997; 19: 65-8.
154. Brownson R. C. Evidence-based Public Health. Oxford: Oxford University Press, 2003.
155. Heller R. F., Heller T. D., Pattison S. Putting the public back into public health. Part I. A re-definition of public health. Public Health 2003; 117: 62-5.
156. Heller R. F., Heller T. D., Pattison S. Putting the public back into public health. Part II. How can public health be accountable to the public? Public Health 2003; 117: 66-71.
157. Popper K. The Logic of Scientific Discovery (translation of Logik der Forschung). London: Hutchinson, 1959.
158. Merzel C. and D'Afflitti J. Reconsidering community-based health promotion:promise, performance, and potential. Am. J. Public Health 2003; 93: 557-74.
159. Ebrahim S. and Smith G. D. Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease.. BMJ 1997; 314: 1666-74.
160. Ebrahim S. and Smith G. D. Effects of the Heartbeat Wales programme. Effects of government policies on health behaviour must be studied. BMJ 1998; 317: 886.
161. Bauman K. E., Suchindran C. M., Murray D. M. The paucity of effects in community trials: is secular trend the culprit? Prev. Med. 1999; 28: 426-9.
162. Hallfors D., Cho H., Livert D., Kadushin C. Fighting back against substance abuse: are community coalitions winning? Am. J. Prev. Med. 2002; 23: 237-45.